E-LIB Suche - Ergebnisse für: Eichler, H-G

1

Incorporating patient preferences into drug development and..:

Postmus, D ; Mavris, M ; Hillege, HL...
Clinical Pharmacology & Therapeutics. 99 (2016) 5 - p. 548-554 , 2016

Link: https://doi.org/10.1002/..

2

Pharmaceuticals Licensing and Reimbursement in the European..:

Oye, KA ; Eichler, HG ; Hoos, A...
Clinical Pharmacology & Therapeutics. 100 (2016) 6 - p. 626-632 , 2016

Link: https://doi.org/10.1002/..

3

"Threshold‐crossing": A Useful Way to Establish the Counter..:

Eichler, H‐G ; Bloechl‐Daum, B ; Bauer, P...
Clinical Pharmacology & Therapeutics. 100 (2016) 6 - p. 699-712 , 2016

Link: https://doi.org/10.1002/..

4

Real World Data in Adaptive Biomedical Innovation: A Framew..:

Schneeweiss, S ; Eichler, H‐G ; Garcia‐Altes, A...
Clinical Pharmacology & Therapeutics. 100 (2016) 6 - p. 633-646 , 2016

Link: https://doi.org/10.1002/..

5

Structured Frameworks to Increase the Transparency of the A..:

Pignatti, F ; Ashby, D ; Brass, EP...
Clinical Pharmacology & Therapeutics. 98 (2015) 5 - p. 522-533 , 2015

Link: https://doi.org/10.1002/..

6

From adaptive licensing to adaptive pathways: Delivering a ..:

Eichler, H‐G ; Baird, LG ; Barker, R...
Clinical Pharmacology & Therapeutics. 97 (2015) 3 - p. 234-246 , 2015

Link: https://doi.org/10.1002/..

7

Accelerated Access to Innovative Medicines for Patients in ..:

Baird, L G ; Banken, R ; Eichler, H-G...
Clinical Pharmacology & Therapeutics. 96 (2014) 5 - p. 559-571 , 2014

Link: https://doi.org/10.1038/..

8

A Proposal for Integrated Efficacy-to-Effectiveness (E2E) C..:

Selker, H P ; Oye, K A ; Eichler, H-G...
Clinical Pharmacology & Therapeutics. 95 (2013) 2 - p. 147-153 , 2013

Link: https://doi.org/10.1038/..

9

Adaptive Licensing: Taking the Next Step in the Evolution o..:

Eichler, H-G ; Oye, K ; Baird, L G...
Clinical Pharmacology & Therapeutics. 91 (2012) 3 - p. 426-437 , 2012

Link: https://doi.org/10.1038/..

10

Advancing the Science of Medicines Regulation: The Role of ..:

Lumpkin, M M ; Eichler, H-G ; Breckenridge, A...
Clinical Pharmacology & Therapeutics. , 2012

Link: https://doi.org/10.1038/..

11

European Perspective on Risk Management and Drug Safety:

Raine, J ; Wise, L ; Blackburn, S..
Clinical Pharmacology & Therapeutics. 89 (2011) 5 - p. 650-654 , 2011

Link: https://doi.org/10.1038/..

12

PCN9 CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV)—OUTCOM..:

Ehlken, B ; Ihbe-Heffinger, A ; Berger, K...
Value in Health. 6 (2003) 6 - p. 734 , 2003

Link: https://doi.org/10.1016/..

13

C-myc gene expression positively correlates with metastatic..:

Schlagbauer-Wadl, H ; Griffioen, M ; van, Elsas A...
Melanoma Research. 7 (1997) Supplement 1 - p. S6 , 1997

Link: https://doi.org/10.1097/..

14

Downregulation of bcl-2 by antisense oligonucleotides reduc..:

Jansen, B ; Wadl, H ; Brown, D B...
Melanoma Research. 7 (1997) Supplement 1 - p. S139 , 1997

Link: https://doi.org/10.1097/..

15

Nitric Oxide Synthase Inhibition in the Histamine Headache ..:

Schmetter, L ; Wolzt, M ; Graselli, U...
Cephalalgia. 17 (1997) 3 - p. 175-182 , 1997

Link: https://doi.org/10.1046/..